High-risk HPV-positive human cancer cell lines show different sensitivity to cisplatin-induced apoptosis correlated with the p21(Waf1/Cip1)level

Cancer Letters

Volumn 108, Issue 1, 1996, Pages 15-23

  Funaoka, Kohsei ^a   Shindoh, Masanobu ^a,b   Yamashita, Toshiharu ^b   Fujinaga, Kei ^b   Amemiya, Akira ^a   Totsuka, Yasunori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Cisplatin; Human papillomavirus (HPV); p21(WAF1 Cip1); p53

Indexed keywords

CISPLATIN; DNA; MESSENGER RNA; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA DAMAGE; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; PRIORITY JOURNAL; WART VIRUS;

APOPTOSIS; CELL CYCLE; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HELA CELLS; HUMANS; IN SITU HYBRIDIZATION; KB CELLS; KERATINOCYTES; NEOPLASM PROTEINS; NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0030581611     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04362-5     Document Type: Article

References (28)

1. [1] Fritsche, M., Haessler, C. and Brandner, G. (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents (published erratum appears in Oncogene (1993) 8(9), 2605), Oncogene, 8, 307-318.
2. [2] Allday, M.J., Sinclair, A., Parker, G., Crawford, D.H. and Farrell, P.J. (1995) Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53, EMBO J., 14, 1382-1391.
3. [3] El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817-825.
4. [4] El-Deiry, W.S., Harper, J.W., O'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., Pietenpol, J.A., Burrell, M., Hill, D.E. and Wang, Y. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis, Cancer Res., 54, 1169-1174.
5. [5] Hengst, L., Dulic, V., Slingerland, J.M., Lees, E. and Reed, S.I. (1994) A cell cycle-regulated inhibitor of cyclin-dependent kinases, Proc. Natl. Acad. Sci. USA, 91, 5291-5295.
6. [6] Luo, Y., Hurwitz, J. and Massague, J. (1995) Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1, Nature, 375, 159-161.
7. [7] Chen, J., Jackson, P.K., Kirschner, M.W. and Dutta, A. (1995) Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA, Nature, 374, 386-388.
8. [8] Johnson, T.L., Kim, W., Plieth, D.A. and Sarkar, F.H. (1992) Detection of HPV 16/18 DNA in cervical adenocarcinoma using polymerase chain reaction (PCR) methodology, Mod. Pathol., 5, 35-40.
9. [9] Miller, C.S., Zeuss, M.S. and White, D.K. (1994) Detection of HPV DNA in oral carcinoma using polymerase chain reaction together with in situ hybridization, Oral Surg. Oral Med. Oral Pathol., 77, 480-486.
10. [10] Shindoh, M., Sawada, Y., Kohgo, T., Amemiya, A. and Fujinaga, K. (1992) Detection of human papillomavirus DNA sequences in tongue squamous-cell carcinoma utilizing the polymerase chain reaction method. Int. J. Cancer, 50, 167-171.
11. [11] Pirisi, L., Batova, A., Jenkins, G.R., Hodam, J.R. and Creek, K.E. (1992) Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids, Cancer Res., 52, 187-193.
12. [12] Munger, K., Scheffner, M., Huibregtse, J.M. and Howley, P.M. (1992) Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products (Review), Cancer Surv., 12, 197-217.
13. [13] Yasumoto, S., Burkhardt, A.L., Doniger, J. and DiPaolo, J.A. (1986) Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells, J Virol., 57, 572-577.
14. [14] Huibregtse, J.M., Scheffner, M. and Howley, P.M. (1993) Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53, Mol. Cell. Biol., 13, 775-784.
15. [15] Huibregtse, J.M., Scheffner, M. and Howley, P.M. (1993) Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins, Mol. Cell. Biol., 13, 4918-4927.
16. [16] Ogura, H., Yoshinouchi, M., Kudo, T., Imura, M., Fujiwara, T. and Yabe, Y. (1993) Human papillomavirus type 18 DNA in so-called HEP-2, KB and FL cells: further evidence that these cells are HeLa cell derivatives, Cell. Mol. Biol., 39, 463-467.
17. [17] Schwarz, E., Freese, U.K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A. and zur Hausen, H. (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells, Nature, 314, 111-114.
18. [18] Yee, C., Krishnan-Hewlett, I., Baker, C.C., Schlegel, R. and Howley, P.M. (1985) Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines, Am. J. Pathol., 119, 361-366.
19. [19] Schreiber, E., Matthias, P., Muller, M.M. and Schaffner, W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res., 17, 6419.
20. [20] Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor University Press, Cold Spring Harbor, 1989.
21. [21] Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M.A., Lassota, P. and Traganos, F. (1992) Features of apoptotic cells measured by flow cytometry, Cytometry, 13, 795-808.
22. [22] Sheikh, M.S., Li, X.S., Chen, J.C., Shao, Z.M., Ordonez, J.V. and Fontana, J.A. (1994) Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways, Oncogene, 9, 3407-3415.
23. [23] Steinman, R.A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D.A. and el-Houseini, M.E. (1994) Induction of p21 (WAF-1/CIP1) during differentiation, Oncogene, 9, 3389-3396.
24. [24] Yang, Z.Y., Perkins, N.D., Ohno, T., Nabel, E.G. and Nabel, G.J. (1995) The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo (see comments), Nature Med., 1, 1052-1056.
25. [25] Butz, K., Shahabeddin, L., Geisen, C., Spitkovsky, D., Ullmann, A. and Hoppe, S.F. (1995) Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene, 10, 927-936.
26. [26] Werness, B.A., Levine, A.J. and Howley, P.M. (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53, Science, 248, 76-79.
27. [27] Scheffner, M., Huibregtse, J.M., Vierstra, R.D. and Howley, P.M. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53, Cell, 75, 495-505.
28. [28] Lechner, M.S. and Laimins, L.A. (1994) Inhibition of p53 DNA binding by human papillomavirus E6 proteins, J. Virol., 68, 4262-4273.